Autism is hard to diagnose-there’s currently no medical test to diagnose the disorder, and teams of experts typically make diagnosis decisions based on their assessments of patients’ behavior. NeuroPointDX aims to change that with a test that could potentially diagnose the condition by analyzing the metabolism of a child from a small blood sample.
NeuroPoint, a business division of Madison, WI-based Stemina Biomarker Discovery focused on diagnostics for neurological disorders, is now turning to the autism community to support its efforts to validate its blood test. The company is seeking to raise $50,000 or more through a new crowdfunding campaign. NeuroPoint… Read more »
UNDERWRITERS AND PARTNERS